Areas Under Investigation in Ph-Like ALL
Sarah K. Tasian, MD, discusses what she finds most interesting about Philadelphia chromosome (Ph-like) acute lymphoblastic leukemia.
Sarah K. Tasian, MD, attending physician and assistant professor of pediatrics in the Division of Oncology at Children’s Hospital of Philadelphia, discusses what she finds most interesting about Philadelphia chromosome (Ph-like) acute lymphoblastic leukemia (ALL).
Tasian is surprised by how heterogenous the disease is and how they are always discovering new fusions. Despite the number of lesions, she says patients have either 1 of 2 pathways:BCR-ABLor CRLF2-R/JAK.
Connecting Heart Disease and Hematologic Malignancies
November 28th 2023A real-world analysis found that patients with acute coronary syndrome who were also diagnosed with a hematologic malignancy had worse survival outcomes, and patients with multiple myeloma were overrepresented in the population.
Read More
